About

Publications While At HealthPartners

selected publications

Journal Article

Which trial do we need? Treatment of multiple erythema migrans with doxycycline for 7 days versus 14 days. 

Clinical Microbiology and Infection. 2024

SARS-CoV-2 vaccination and clinical presentation of COVID-19 in patients hospitalized during the Delta- and Omicron-predominant periods. 

Journal of clinical medicine. 2023

Treatment of erythema migrans with doxycycline for 7 days versus 14 days in Slovenia: a randomised open-label non-inferiority trial. 

Lancet Infectious Diseases. 2023

The impact of SARS-CoV-2 primary vaccination in a cohort of patients hospitalized for acute COVID-19 during Delta variant predominance. 

Journal of clinical medicine. 2022

Association between statin use and clinical course, microbiologic characteristics, and long-term outcome of early Lyme borreliosis. A post hoc analysis of prospective clinical trials of adult patients with erythema migrans. 

PloS One. 2021

Clinical manifestations and long-term outcome of early Lyme neuroborreliosis according to the European Federation of Neurological Societies diagnostic criteria (definite versus possible) in central Europe. A retrospective cohort study. 

European Journal of Neurology. 2021

Systemic immune responses in patients with early localized or early disseminated Borrelia afzelii lyme borreliosis. 

Immunity, inflammation and disease. 2021

Contact

full name

D. Stupica

Quick Info

 

Collaboration

Co-author network

Map of science